デフォルト表紙
市場調査レポート
商品コード
1084774

細胞凍結保存の世界市場の動向・展望・機会の分析 (2022年~2028年):製品タイプ (凍結保護剤・フリーザー・その他)・用途・エンドユーザー・地域別

Cell Cryopreservation Market, by Product Type (Cryopreservative Medium, Freezers, and Others), by Application, by End User and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 192 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
細胞凍結保存の世界市場の動向・展望・機会の分析 (2022年~2028年):製品タイプ (凍結保護剤・フリーザー・その他)・用途・エンドユーザー・地域別
出版日: 2022年05月19日
発行: Coherent Market Insights
ページ情報: 英文 192 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

参入事業者による製品発売の増加が世界の細胞凍結保存市場の成長を促進する主な要因です。また、出生率の低下も市場成長の原動力となることが予想されています。

当レポートでは、世界の細胞凍結保存の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・法規制・動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 提携・買収
  • 新製品の発売
  • 規制シナリオ
  • M&Aシナリオ
  • PEST分析
  • ポーターの分析

第4章 世界の細胞凍結保存市場:製品タイプ別

  • 凍結保護剤
  • 機器

第5章 世界の細胞凍結保存市場:用途別

  • 幹細胞
  • 卵母細胞・胚
  • 精子・精液・精巣組織
  • 肝細胞
  • その他

第6章 世界の細胞凍結保存市場:エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • バイオバンク
  • その他

第7章 世界の細胞凍結保存市場:地域別

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第8章 競合情勢

  • 企業プロファイル
    • General Electric Company
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • AMS Biotechnology(Europe)Limited
    • Miltenyi Biotec GmbH
    • Corning Incorporated
    • BioLifeSolutions Inc.
    • HiMedia Laboratories Pvt. Ltd.
    • PromoCell GmbH
    • Cooper Companies, Inc.
    • Planer PLC

第9章 セクション

目次
Product Code: CMI1698

The process of stabilizing biological materials at cryogenic temperatures (below -1500 degree C) is called cryopreservation. Cryopreservation is used for the preservation of microorganisms, tissue cells, established cell-lines, small multicellular organisms, and complex cellular structures such as embryos, nucleic acid, and proteins. Cryopreservation procedures use liquid nitrogen, liquid helium, argon, and oxygen as cryogenic elements. Various types of samples with varying sensitivity require different types of cryopreservation equipment such as cryopreservation freezers, liquid nitrogen vessels, cryogenic vaporizers, cryogenic incubators, liquid tracking equipment, and cell freezing container.

Market Dynamics

Increasing product launches by market players is a major factor driving the global cell cryopreservation market growth. For instance, in 2021, Irvine Scientific, a manufacturer of cell culture media, introduced Arctic Sperm Cryopreservation Medium to improve the post-thaw performance of frozen sperm samples and reduce the cost of sperm cryopreservation.

Furthermore, decrease in fertility rate is expected to drive the market growth. According to the Journal of Human Reproductive Sciences, 2015, around 40-80% of females face possible infertility as a result of their cancer treatments that is, chemotherapy, radiation, and surgery.

Key features of the study:

  • This report provides in-depth analysis of the global cell cryopreservation market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global cell cryopreservation market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Miltenyi Biotec GmbH, BioLifeSolutions Inc., HiMedia Laboratories Pvt. Ltd., PromoCell GmbH, Corning Incorporated, Cooper Companies, Inc., and Planer PLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

Detailed Segmentation:

  • Global Cell Cryopreservation Market, By Product Type:
    • Cryoprotectant Agents
      • Glycerol
      • Dimethyl Sulfoxide (DMSO)
      • Others
    • Equipment
      • Incubators
      • Liquid Nitrogen Supply Tanks
      • Freezers
      • Others
  • Global Cell Cryopreservation Market, By Application:
    • Stem Cells
    • Oocytes and Embryos
    • Sperm, Semen, and Testicular Tissue
    • Hepatocytes
    • Others
  • Global Cell Cryopreservation Market, By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Biobank
    • Others
  • Global Cell Cryopreservation Market, By Region:
    • North America
      • By Product Type:
      • Cryoprotectant Agents
      • Glycerol
      • Dimethyl Sulfoxide (DMSO)
      • Others
      • Equipment
      • Incubators
      • Liquid Nitrogen Supply Tanks
      • Freezers
      • Others
      • By Application:
      • Stem Cells
      • Oocytes and Embryos
      • Sperm, Semen, and Testicular Tissue
      • Hepatocytes
      • Others
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Academic and Research Institutes
      • Biobank
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Cryoprotectant Agents
      • Glycerol
      • Dimethyl Sulfoxide (DMSO)
      • Others
      • Equipment
      • Incubators
      • Liquid Nitrogen Supply Tanks
      • Freezers
      • Others
      • By Application:
      • Stem Cells
      • Oocytes and Embryos
      • Sperm, Semen, and Testicular Tissue
      • Hepatocytes
      • Others
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Academic and Research Institutes
      • Biobank
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Cryoprotectant Agents
      • Glycerol
      • Dimethyl Sulfoxide (DMSO)
      • Others
      • Equipment
      • Incubators
      • Liquid Nitrogen Supply Tanks
      • Freezers
      • Others
      • By Application:
      • Stem Cells
      • Oocytes and Embryos
      • Sperm, Semen, and Testicular Tissue
      • Hepatocytes
      • Others
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Academic and Research Institutes
      • Biobank
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Cryoprotectant Agents
      • Glycerol
      • Dimethyl Sulfoxide (DMSO)
      • Others
      • Equipment
      • Incubators
      • Liquid Nitrogen Supply Tanks
      • Freezers
      • Others
      • By Application:
      • Stem Cells
      • Oocytes and Embryos
      • Sperm, Semen, and Testicular Tissue
      • Hepatocytes
      • Others
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Academic and Research Institutes
      • Biobank
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Cryoprotectant Agents
      • Glycerol
      • Dimethyl Sulfoxide (DMSO)
      • Others
      • Equipment
      • Incubators
      • Liquid Nitrogen Supply Tanks
      • Freezers
      • Others
      • By Application:
      • Stem Cells
      • Oocytes and Embryos
      • Sperm, Semen, and Testicular Tissue
      • Hepatocytes
      • Others
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Academic and Research Institutes
      • Biobank
      • Others
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Cryoprotectant Agents
      • Glycerol
      • Dimethyl Sulfoxide (DMSO)
      • Others
      • Equipment
      • Incubators
      • Liquid Nitrogen Supply Tanks
      • Freezers
      • Others
      • By Application:
      • Stem Cells
      • Oocytes and Embryos
      • Sperm, Semen, and Testicular Tissue
      • Hepatocytes
      • Others
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Academic and Research Institutes
      • Biobank
      • Others
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • General Electric Company*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • AMS Biotechnology (Europe) Limited
    • Miltenyi Biotec GmbH
    • BioLifeSolutions Inc.
    • HiMedia Laboratories Pvt. Ltd.
    • PromoCell GmbH
    • Corning Incorporated
    • Cooper Companies, Inc.
    • Planer PLC

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Collaboration and Acquisitions
  • New Product Launches
  • Regulatory Scenario
  • Merger and Acquisition Scenario
  • PEST Analysis
  • PORTER'S Analysis

4. Global Cell Cryopreservation Market, By Product Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cryoprotectant Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others

5. Global Cell Cryopreservation Market, By Application, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Oocytes and Embryos
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Sperm, Semen, and Testicular Tissue
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Hepatocytes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Cell Cryopreservation Market, By End User, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Biobank
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Cell Cryopreservation Market , By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Company Profiles
    • General Electric Company
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Thermo Fisher Scientific Inc.
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck KGaA
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AMS Biotechnology (Europe) Limited
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Miltenyi Biotec GmbH
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Corning Incorporated
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BioLifeSolutions Inc.
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • HiMedia Laboratories Pvt. Ltd.
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • PromoCell GmbH
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cooper Companies, Inc.
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Planer PLC
    • Company Overview
    • Disease Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact